Eric M Ammann1, Marin L Schweizer2,3, Jennifer G Robinson1,3,4, Jayasheel O Eschol3, Rami Kafa3, Saket Girotra3,4, Scott K Winiecki5, Candace C Fuller6, Ryan M Carnahan1, Charles E Leonard7, Cole Haskins1,4,8, Crystal Garcia6, Elizabeth A Chrischilles1. 1. College of Public Health, University of Iowa, Iowa City, IA, USA. 2. Iowa City VA Health Care System, Iowa City, IA, USA. 3. University of Iowa Hospitals and Clinics, Iowa City, IA, USA. 4. Carver College of Medicine, University of Iowa, Iowa City, IA, USA. 5. Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. 6. Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. 7. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 8. Medical Scientist Training Program, University of Iowa, Iowa City, IA, USA.
Abstract
BACKGROUND: The Sentinel Distributed Database (SDD) is a large database of patient-level administrative health care records, primarily derived from insurance claims and electronic health records, and is sponsored by the US Food and Drug Administration for medical product safety evaluations. Acute myocardial infarction (AMI) is a common study endpoint for drug safety studies that rely on health records from the SDD and other administrative databases. PURPOSE: In this chart validation study, we report on the positive predictive value (PPV) of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification AMI administrative diagnosis codes (410.x1 and 410.x0) in the SDD. METHODS: As part of an assessment of thromboembolic adverse event risk following treatment with intravenous immune globulin, charts were obtained for 103 potential post-intravenous immune globulin AMI cases. Charts were abstracted by trained nurses and physician-adjudicated based on prespecified diagnostic criteria. RESULTS: Acute myocardial infarction status could be determined for 89 potential cases. The PPVs for the inpatient AMI diagnoses recorded in the SDD were 75% overall (95% CI, 65-84%), 93% (95% CI, 78-99%) for principal-position diagnoses, 88% (95% CI, 72-97%) for secondary diagnoses, and 38% (95% CI, 20-59%) for position-unspecified diagnoses (eg, diagnoses originating from separate physician claims associated with an inpatient stay). Of the confirmed AMI cases, demand ischemia was the suspected etiology more often for those coded in secondary or unspecified positions (72% and 40%, respectively) than for principal-position AMI diagnoses (21%). CONCLUSIONS: The PPVs for principal and secondary AMI diagnoses were high and similar to estimates from prior chart validation studies. Position-unspecified diagnosis codes were less likely to represent true AMI cases.
BACKGROUND: The Sentinel Distributed Database (SDD) is a large database of patient-level administrative health care records, primarily derived from insurance claims and electronic health records, and is sponsored by the US Food and Drug Administration for medical product safety evaluations. Acute myocardial infarction (AMI) is a common study endpoint for drug safety studies that rely on health records from the SDD and other administrative databases. PURPOSE: In this chart validation study, we report on the positive predictive value (PPV) of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification AMI administrative diagnosis codes (410.x1 and 410.x0) in the SDD. METHODS: As part of an assessment of thromboembolic adverse event risk following treatment with intravenous immune globulin, charts were obtained for 103 potential post-intravenous immune globulin AMI cases. Charts were abstracted by trained nurses and physician-adjudicated based on prespecified diagnostic criteria. RESULTS:Acute myocardial infarction status could be determined for 89 potential cases. The PPVs for the inpatient AMI diagnoses recorded in the SDD were 75% overall (95% CI, 65-84%), 93% (95% CI, 78-99%) for principal-position diagnoses, 88% (95% CI, 72-97%) for secondary diagnoses, and 38% (95% CI, 20-59%) for position-unspecified diagnoses (eg, diagnoses originating from separate physician claims associated with an inpatient stay). Of the confirmed AMI cases, demand ischemia was the suspected etiology more often for those coded in secondary or unspecified positions (72% and 40%, respectively) than for principal-position AMI diagnoses (21%). CONCLUSIONS: The PPVs for principal and secondary AMI diagnoses were high and similar to estimates from prior chart validation studies. Position-unspecified diagnosis codes were less likely to represent true AMI cases.
Authors: Susan Forrow; Daniel M Campion; Lisa J Herrinton; Vinit P Nair; Melissa A Robb; Marcus Wilson; Richard Platt Journal: Pharmacoepidemiol Drug Saf Date: 2012-01 Impact factor: 2.890
Authors: Susan R Heckbert; Charles Kooperberg; Monika M Safford; Bruce M Psaty; Judith Hsia; Anne McTiernan; J Michael Gaziano; William H Frishman; J David Curb Journal: Am J Epidemiol Date: 2004-12-15 Impact factor: 4.897
Authors: Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles Journal: J Allergy Clin Immunol Date: 2006-04 Impact factor: 10.793
Authors: Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon Journal: Am Heart J Date: 2004-07 Impact factor: 4.749
Authors: Vincent Lo Re; Sarah K Dutcher; John G Connolly; Silvia Perez-Vilar; Dena M Carbonari; Terese A DeFor; Djeneba Audrey Djibo; Laura B Harrington; Laura Hou; Sean Hennessy; Rebecca A Hubbard; Maria E Kempner; Jennifer L Kuntz; Cheryl N McMahill-Walraven; Jolene Mosley; Pamala A Pawloski; Andrew B Petrone; Allyson M Pishko; Meighan Rogers Driscoll; Claudia A Steiner; Yunping Zhou; Noelle M Cocoros Journal: JAMA Date: 2022-08-16 Impact factor: 157.335
Authors: Rohan Khera; Martijn J Schuemie; Yuan Lu; Anna Ostropolets; RuiJun Chen; George Hripcsak; Patrick B Ryan; Harlan M Krumholz; Marc A Suchard Journal: BMJ Open Date: 2022-06-09 Impact factor: 3.006
Authors: Kael Wherry; Kurt Stromberg; Jennifer A Hinnenthal; Lisa A Wallenfelsz; Mikhael F El-Chami; Lindsay Bockstedt Journal: Pragmat Obs Res Date: 2020-02-28